-
Seasonal Shot StrategiesResearchers find that patients with cancer who are severely immunocompromised may benefit from a more frequent seasonal vaccine schedule.
by Sandra Gordon
-
Drop in Cancer Diagnoses Under COVID-19 Raises AlarmsResults of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
by Kyle Bagenstose
-
T Cells Key to COVID-19 Vaccination EffortsExperts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.
by Thomas Celona
-
More Data on COVID-19 Vaccination and CancerStudies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
by Anna Goshua
-
Building COVID-19 Vaccine ConfidenceExperts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.
by Kevin McLaughlin
Instead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
Advocacy After LossFollowing her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
Telehealth Palliative Care Provides the Same Benefits as In-person CareResearchers hope effective telehealth will increase access to palliative care for more cancer patients.
by Taneia Surles
Sensorimotor Training Helps Prevent Chemotherapy-induced Peripheral NeuropathyThe specialized balance training exercise can help keep the nervous system healthy during chemotherapy by giving it a workout.
by Sandra Gordon
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
